Dr. Reddy’s Laboratories enters hospital nutrition segment with Celevida Maxx in India
News Desk, News nation 360: Dr. Reddy’s Laboratories Ltd. announced the entry into the hospital nutrition segment with the launch of its nutrition drink, Celevida Maxx in India. It is a unique addition to Dr. Reddy’s nutrition portfolio and is designed to help manage the nutritional needs of Cancer, Critical Care and Chronic Obstructive Pulmonary Disease (COPD) patients in India. Dr. Reddy’s Celevida Maxx contains a unique triple action formula of high protein, high omega 3 fatty acids to help tackle the problem of inflammation and Astaxanthin, which is clinically proven to support immunity. A single serving of Celevida Maxx has been designed keeping patient compliance in mind. It offers high protein in a single-serve of 33 gms, with medium-chain triglycerides (MCT) that get easily absorbed in the body and readily provide energy. Malnourished patients need a ready source of energy that can be easily
absorbed with high protein thereby helping stabilize the rapid weight loss that is seen in conditions like cancer. Celevida Maxx contains vegetarian ingredients, no added sugar and comes in two flavours, Orange and Strawberry. M V Ramana, Chief Executive Officer, Branded Markets (India and Emerging Markets), Dr. Reddy’s Laboratories told they are pleased to foray into the hospital nutrition segment in India. With Celevida Maxx, they look forward to strengthening their presence in the nutrition segment and continue making a positive impact on patients’ lives.
Report : Anustup Kundu